je.st
news
Tag: cancer
New Data Evaluating KEYTRUDA (pembrolizumab) in Combination with Chemotherapy for First-Line Treatment of Non-Small Cell Lung Cancer Demonstrate Response Rates Ranging from 48 to 71 Percent
2016-06-04 14:00:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Based on Initial Results Presented at 2016 ASCO Annual Meeting, Merck Has Initiated Two Phase 3 Studies KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced findings from an initial proof-of-concept study of KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, combined with standard treatments, one with bevacizumab and others without, in non-small cell lung cancer (NSCLC) including chemotherapy in previously untreated patients with NSCLC; the study showed overall response rates (ORR) ranging from 48 to 71 percent, depending on the therapy used. Language: English Contact: MerckMedia Contacts:Pamela Eisele, (267) 305-3558orCourtney Ronaldo, (908) 236-1108orInvestor Contacts:Teri Loxam, (908) 740-1986orJustin Holko, (908) 740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Axalta Coating Systems in Belgium Cycles 1,000 km for Cancer Charity
2016-05-26 20:07:00| Coatings World Breaking News
Tags: systems
cancer
belgium
charity
Merck Foundation Announces the Alliance to Advance Patient-Centered Cancer Care, a $15 Million Initiative to Improve Access to High-Quality Cancer Care in Underserved Communities in the United States
2016-05-23 15:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Merck Foundation Accepting Applications from Non-Profit Organizations KENILWORTH, N.J.--(BUSINESS WIRE)--The Merck Foundation announced today the launch of a new initiative, the Alliance to Advance Patient-Centered Cancer Care (the Alliance), to support programs aimed at improving timely access to patient-centered care and reduce disparities in cancer care, especially for vulnerable and underserved populations in the United States. Language: English Contact: Media:Lainie Keller, 908-236-5036orCourtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Alcohol consumption and the risk of breast cancer and heart disease - International Scientific Forum on Alcohol Research Critique 186
2016-05-19 17:12:00| Daily beverage news and comment - from just-drinks.com
A large study from Denmark was designed to test the hypothesis that women who increase their alcohol intake over a five-year period have a higher risk of breast cancer and a lower risk of coronary heart disease (CHD) compared with women who exhibit a stable alcohol intake.
Tags: forum
international
research
heart
Alcohol consumption on the risk of breast cancer and heart disease - International Scientific Forum on Alcohol Research Critique 186
2016-05-19 17:08:30| Daily beverage news and comment - from just-drinks.com
A large study from Denmark was designed to test the hypothesis that women who increase their alcohol intake over a five-year period have a higher risk of breast cancer and a lower risk of coronary heart disease (CHD) compared with women who exhibit a stable alcohol intake.
Tags: forum
international
research
heart
Sites : [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] next »